Skip to content

Application of glomerular filtration rate decline rate to Optimize Timing of Pre-emptive Arteriovenous fistula Creation for Chronic Kidney Disease Patients

Application of glomerular filtration rate decline rate to Optimize Timing of Pre-emptive Arteriovenous fistula Creation for Chronic Kidney Disease Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240326006
Enrollment
70
Registered
2024-03-26
Start date
2022-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD G5, eGFR below 15 ml/min/1.73 m2 which plan for AVF operations. Pre-emptive arteriovenous fistula, Chronic kidney disease, GFR trajectory

Interventions

CKD G5 patients who were candidate for preemptive AVF creation
Diagnostic
CKD G5 patients

Sponsors

Naresuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: encompassed subjects without peripheral artery disease in the upper extremity and with sufficient vein quality confirmed through duplex ultrasonography prior to AVF creation. A uniform pre-operative assessment of vessel quality was carried out using duplex ultrasound in both institutions. The assessment followed the criteria set forth in the KDOQI guideline 2006, which specifies that vessel quality is determined by an arterial diameter exceeding 2.5 mm with a detectable distal pulse, and a superficial vein diameter of over 3 mm with consistent integrity. These criteria establish the suitability for autogenous arteriovenous fistula (AVF) creation.

Exclusion criteria

Exclusion criteria: patients with incomplete eGFR data within the 12 months preceding referral for AVF creation, those who passed away before initiating hemodialysis, and individuals with acute illness and acute kidney injury without recovery to baseline GFR.

Design outcomes

Primary

MeasureTime frame
The time remaining before the initiation of hemodialysis until 31st Dec 2022 days at baseline, 2 mo, 4 mo, 6 mo, 8 mo, 10 mo, and 12 mo before starting hemodialysis

Secondary

MeasureTime frame
A functioning arteriovenous fistula (AVF) until 31st Dec 2022 Binary outcome (Yes/No) at baseline, 2 mo, 4 mo, 6 mo, 8 mo, 10 mo, and 12 mo before starting hemodialysis

Countries

Thailand

Contacts

Public ContactPanuwat Chuemor

Faculty of Medicine, Naresuan University

chuemor35707@gmail.com0894017007

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026